Agios Pharmaceuticals, Inc.
AGIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001439222
In the last 90 days, Agios Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 2 sales; 238 institutions reported holding it in 13F filings for Q2 2026, worth $2.45B in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Agios Pharmaceuticals, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 186
- +12 vs. Q1 2021
- Shares held
- 65.9M
- +682.0K (+1.0%) vs. Q1 2021
- Total value
- $3.63B
- +$266.1M (+7.9%) vs. Q1 2021
- New holders
- 39
- 50 more added
- Sold out
- 27
- 62 more reduced
1 institution that held it in Q1 2021 haven't filed for Q2 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AGIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 238 | $2.45B |
| Q1 2026 | 234 | $2.12B |
| Q4 2025 | 238 | $1.67B |
| Q3 2025 | 221 | $2.55B |
| Q2 2025 | 216 | $2.05B |
| Q1 2025 | 221 | $1.76B |
| Q4 2024 | 225 | $1.97B |
| Q3 2024 | 208 | $2.58B |
| Q2 2024 | 206 | $2.51B |
| Q1 2024 | 187 | $1.81B |
| Q4 2023 | 170 | $1.33B |
| Q3 2023 | 146 | $1.46B |
| Q2 2023 | 153 | $1.68B |
| Q1 2023 | 165 | $1.36B |
| Q4 2022 | 160 | $1.67B |
| Q3 2022 | 168 | $1.64B |
| Q2 2022 | 157 | $1.31B |
| Q1 2022 | 161 | $1.74B |
| Q4 2021 | 161 | $1.95B |
| Q3 2021 | 165 | $2.81B |
| Q2 2021 | 186 | $3.63B |
| Q1 2021 | 175 | $3.37B |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Agios Pharmaceuticals, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| GAM Holding AG | 0 | $0 | 0.00% | −10,527−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −7,690−100.0% | Sold out |
| Pearl River Capital, LLC | 0 | $0 | 0.00% | −7,527−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −6,894−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −5,946−100.0% | Sold out |
| Maryland State Retirement & Pension System | 0 | $0 | 0.00% | −5,068−100.0% | Sold out |
| Quantitative Systematic Strategies LLC | 0 | $0 | 0.00% | −4,661−100.0% | Sold out |
| Maverick Capital LtdSuperinvestorMaverick Capital | 0 | $0 | 0.00% | −4,042−100.0% | Sold out |
| Sowell Financial Services LLC | 0 | $0 | 0.00% | −2,126−100.0% | Sold out |
| Pacer Advisors, Inc. | 0 | $0 | 0.00% | −1,504−100.0% | Sold out |
| Grace Capital | 0 | $0 | 0.00% | −1,300−100.0% | Sold out |
| Atlas Private Wealth Advisors | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −87−100.0% | Sold out |
| Amundi Asset Management US, Inc. | – | – | – | – | Not filed |